Vorapaxar Sulfate
≥98%
- Product Code: 103480
CAS:
705260-08-8
| Molecular Weight: | 590.67 g./mol | Molecular Formula: | C₂₉H₃₃FN₂O₄H₂SO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Vorapaxar sulfate is primarily used in the prevention of thrombotic cardiovascular events. It is specifically prescribed to reduce the risk of heart attack, stroke, cardiovascular death, and other complications in patients with a history of myocardial infarction or peripheral arterial disease. The drug works by inhibiting the protease-activated receptor-1 (PAR-1), which plays a key role in platelet activation and thrombus formation. This targeted mechanism helps prevent excessive blood clotting without significantly increasing the risk of bleeding, making it a valuable option for patients who require long-term antiplatelet therapy. It is often used in combination with other antiplatelet agents like aspirin or clopidogrel to enhance its efficacy in managing cardiovascular risks. However, it is contraindicated in patients with a history of stroke, transient ischemic attack, or intracranial hemorrhage due to the increased risk of bleeding.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $360.23 |
+
-
|
| 0.025 | 10-20 days | $1,242.70 |
+
-
|
Vorapaxar Sulfate
Vorapaxar sulfate is primarily used in the prevention of thrombotic cardiovascular events. It is specifically prescribed to reduce the risk of heart attack, stroke, cardiovascular death, and other complications in patients with a history of myocardial infarction or peripheral arterial disease. The drug works by inhibiting the protease-activated receptor-1 (PAR-1), which plays a key role in platelet activation and thrombus formation. This targeted mechanism helps prevent excessive blood clotting without significantly increasing the risk of bleeding, making it a valuable option for patients who require long-term antiplatelet therapy. It is often used in combination with other antiplatelet agents like aspirin or clopidogrel to enhance its efficacy in managing cardiovascular risks. However, it is contraindicated in patients with a history of stroke, transient ischemic attack, or intracranial hemorrhage due to the increased risk of bleeding.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :